selinexor,Ruxolitinib
karyopharm therapeutics,novartis,incyte
['ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)', 'rux,(-crux),(-trux)', 'selinexor', '$kpti']
$kpti ct261 / 1 - a phase 1, open-label, dose-escalation study of selinexor plus ruxolitinib in patients with treatment-na ve myelofibrosis #aacr23 
L/S biotech. PhD student @UniofOxford